Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
The research, presented at findings at Digestive Disease Week 2025, was led by renowned obesity researcher and Phenomix co-founder, Dr Andres Acosta and presented by Dr Thomas Fredrick, marks an important step toward more personalised obesity care and improved clinical trial design to support drug development
Funding The research was supported by the Ministry of Science and Technology (Taiwan) (108-2314-B-002-032, 106-2314-B-002 -039 -MY3 and 108-2321-B-002 -035, 106-2319-B-492-001, 109-2327-B-002 -005, 109-2314-B-002 -103 -MY3, 109-2314-B-002 -064 -MY3), Program for Translational Innovation of Biopharmaceutical Development-Technology Supporting Platform Axis (AS-KPQ-106-TSPA) and Russian Science Foundation (Grant # 19-15-00010)
This presents an opportunity for consumer packaged goods (CPG) companies and food sellers to introduce new products and retool their marketing strategies with a health-focused spin
Thc t ng lo ngi l sau khi ngng thuc, cm gic i thng c xu hng quay tr li nh c
As research continues to unfold, 5-AMINO-1 MQ is increasingly recognized for its promising applications in health and wellness
These providers operate independently from the technology platform
US$ 23.09
US$ 21.57
US$ 29.05
US$ 27.84
US$ 29.88
US$ 21.55
US$ 21.41
